Page last updated: 2024-12-05
benzo(g)chrysene
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
benzo(g)chrysene: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 9140 |
| MeSH ID | M0263651 |
Synonyms (23)
| Synonym |
|---|
| brn 2212952 |
| 1,2,3,4-dibenzophenanthrene |
| hsdb 4033 |
| 1,2,3,4-dibenzphenanthrene |
| benzo(g)chrysene |
| benzo(a)triphenylene |
| 1,2:3,4:7,8-tribenznaphthalene |
| 196-78-1 |
| benzo[g]chrysene |
| C19340 |
| unii-e7mq64xu75 |
| e7mq64xu75 , |
| AKOS015902195 |
| 1,2:3,4-dibenzophenanthrene |
| benzo(g)chrysene [iarc] |
| 1,2,3,4-dibenzphenanthracene |
| benzo(g)chrysene [hsdb] |
| DTXSID40173267 |
| Q27276977 |
| pentacyclo[12.8.0.02,7.08,13.015,20]docosa-1(14),2,4,6,8,10,12,15,17,19,21-undecaene |
| 1,2,3,4-dibenzophenanthren |
| 1,2,3,4-dibenzphenanthrene; 1,2:3,4-dibenzophenanthrene; 1,2:3,4:7,8-tribenznaphthalene; benzo[a]triphenylene |
| mfcd00215865 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.15
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.15) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||